References
1
Schade DS, Eaton RP. Metabolic and clinical significance of ketosis. Special Topics in Endocrinology
and Metabolism 1982; 4:1–27.
2
Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM. Treatment of
diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the
endpoint of emergency management. Diabetes Care 1997; 20:1347–1352.
3
Harano Y, Kosugi K, Hyosu T, Suzuki M, Hidaka H, Kashiwagi A, Uno S, Shigeta Y. Ketone bodies as
markers for Type 1 (insulin-dependent) diabetes and their value in the monitoring of diabetes
control. Diabetologia 1984; 26:343-348.
4
Ubukata E. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus
and non-insulin-dependent diabetes mellitus patients: The relationship to serum C-peptide
immunoreactivity and free insulin. Ann Nutr Metab 1990; 34:333–342.
5
Luzi L, Barrett EJ, Groop LC, Ferrannini E, DeFronzo RA. Metabolic effects of low-dose insulin
therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 1988; 37:1470–1477.
6
Hale PJ, Crase J, Nattrass M. Metabolic effects of bicarbonate in the treatment of diabetic
ketoacidosis. Br Med J 1984; 289; 1035–1038.
7
American Diabetes Association Position Statement: Diagnosis and classification of diabetes
mellitus. Diabetes Care 2012;35(Suppl.1):S64-S71.
45